Structure

Physi-Chem Properties

Molecular Weight:  420.1
Volume:  401.754
LogP:  5.93
LogD:  2.733
LogS:  -3.448
# Rotatable Bonds:  6
TPSA:  127.45
# H-Bond Aceptor:  7
# H-Bond Donor:  5
# Rings:  3
# Heavy Atoms:  8

MedChem Properties

QED Drug-Likeness Score:  0.165
Synthetic Accessibility Score:  2.958
Fsp3:  0.286
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.158
MDCK Permeability:  1.366139895253582e-05
Pgp-inhibitor:  0.122
Pgp-substrate:  0.0
Human Intestinal Absorption (HIA):  0.802
20% Bioavailability (F20%):  0.023
30% Bioavailability (F30%):  0.981

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.001
Plasma Protein Binding (PPB):  98.5082778930664%
Volume Distribution (VD):  0.463
Pgp-substrate:  3.7571325302124023%

ADMET: Metabolism

CYP1A2-inhibitor:  0.745
CYP1A2-substrate:  0.437
CYP2C19-inhibitor:  0.268
CYP2C19-substrate:  0.06
CYP2C9-inhibitor:  0.786
CYP2C9-substrate:  0.586
CYP2D6-inhibitor:  0.2
CYP2D6-substrate:  0.173
CYP3A4-inhibitor:  0.071
CYP3A4-substrate:  0.038

ADMET: Excretion

Clearance (CL):  4.866
Half-life (T1/2):  0.487

ADMET: Toxicity

hERG Blockers:  0.015
Human Hepatotoxicity (H-HT):  0.073
Drug-inuced Liver Injury (DILI):  0.968
AMES Toxicity:  0.629
Rat Oral Acute Toxicity:  0.036
Maximum Recommended Daily Dose:  0.821
Skin Sensitization:  0.939
Carcinogencity:  0.126
Eye Corrosion:  0.003
Eye Irritation:  0.916
Respiratory Toxicity:  0.264

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC470560

Natural Product ID:  NPC470560
Common Name*:   (-)-(1's)-6-O-Methyl-7-Chloroaverantin
IUPAC Name:   2-chloro-1,6,8-trihydroxy-7-[(1S)-1-hydroxyhexyl]-3-methoxyanthracene-9,10-dione
Synonyms:  
Standard InCHIKey:  KRLUFPHVSFXHOK-NSHDSACASA-N
Standard InCHI:  InChI=1S/C21H21ClO7/c1-3-4-5-6-11(23)16-12(24)7-9-14(20(16)27)19(26)15-10(18(9)25)8-13(29-2)17(22)21(15)28/h7-8,11,23-24,27-28H,3-6H2,1-2H3/t11-/m0/s1
SMILES:  CCCCC[C@@H](c1c(O)cc2c(c1O)C(=O)c1c(C2=O)cc(c(c1O)Cl)OC)O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL2071279
PubChem CID:   60199737
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0002448] Benzenoids
      • [CHEMONTID:0000018] Anthracenes
        • [CHEMONTID:0000151] Anthraquinones
          • [CHEMONTID:0001598] Hydroxyanthraquinones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO31572 Aspergillus sp. Species Aspergillaceae Eukaryota rhizosphere Sonoran desert n.a. PMID[15620238]
NPO31572 Aspergillus sp. Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[17542490]
NPO31572 Aspergillus sp. Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[17564467]
NPO31572 Aspergillus sp. Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[19053517]
NPO31572 Aspergillus sp. Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[21366228]
NPO31572 Aspergillus sp. Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[21718031]
NPO31572 Aspergillus sp. Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[21854017]
NPO31572 Aspergillus sp. Species Aspergillaceae Eukaryota healthy leaf of Ginkgo biloba campus of Nanjing University, Nanjing, China 2008-OCT PMID[22196792]
NPO31572 Aspergillus sp. Species Aspergillaceae Eukaryota isolated from the sponge Xestospongia testudinaria n.a. n.a. PMID[22225637]
NPO31572 Aspergillus sp. Species Aspergillaceae Eukaryota Isolated from a sandy-loam soil sample 50 m inland from Waikiki Beach, Honolulu, Hawaii 2010-JUL PMID[22400916]
NPO31572 Aspergillus sp. Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[22703109]
NPO31572 Aspergillus sp. Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[23527875]
NPO31572 Aspergillus sp. Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[24050204]
NPO31572 Aspergillus sp. Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[25001296]
NPO31572 Aspergillus sp. Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[25581396]
NPO31572 Aspergillus sp. Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[26273902]
NPO31572 Aspergillus sp. Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[31012585]
NPO31572 Aspergillus sp. Species Aspergillaceae Eukaryota n.a. n.a. n.a. PMID[33305943]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT395 Cell Line SF-268 Homo sapiens IC50 = 7110.0 nM PMID[489416]
NPT83 Cell Line MCF7 Homo sapiens IC50 = 6640.0 nM PMID[489416]
NPT397 Cell Line NCI-H460 Homo sapiens IC50 = 7420.0 nM PMID[489416]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC470560 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9938 High Similarity NPC470562
0.9691 High Similarity NPC470565
0.9563 High Similarity NPC470561
0.9503 High Similarity NPC470563
0.9375 High Similarity NPC470559
0.9281 High Similarity NPC264922
0.9277 High Similarity NPC474857
0.9217 High Similarity NPC277865
0.9012 High Similarity NPC470564
0.8914 High Similarity NPC316091
0.8882 High Similarity NPC470569
0.882 High Similarity NPC470568
0.8807 High Similarity NPC313386
0.8786 High Similarity NPC306240
0.8722 High Similarity NPC313541
0.8704 High Similarity NPC290954
0.8704 High Similarity NPC147735
0.8704 High Similarity NPC255641
0.8693 High Similarity NPC191606
0.8671 High Similarity NPC45072
0.8663 High Similarity NPC470422
0.8634 High Similarity NPC289042
0.8634 High Similarity NPC118027
0.8634 High Similarity NPC245584
0.8634 High Similarity NPC126767
0.8634 High Similarity NPC56433
0.8634 High Similarity NPC190648
0.8634 High Similarity NPC312929
0.8629 High Similarity NPC151292
0.8598 High Similarity NPC154683
0.8598 High Similarity NPC40356
0.8529 High Similarity NPC68850
0.8509 High Similarity NPC34482
0.8503 High Similarity NPC197326
0.8476 Intermediate Similarity NPC294646
0.8457 Intermediate Similarity NPC470570
0.8452 Intermediate Similarity NPC324736
0.8447 Intermediate Similarity NPC48762
0.8447 Intermediate Similarity NPC19896
0.8436 Intermediate Similarity NPC474499
0.8434 Intermediate Similarity NPC208806
0.843 Intermediate Similarity NPC472032
0.8405 Intermediate Similarity NPC34802
0.8395 Intermediate Similarity NPC49282
0.8385 Intermediate Similarity NPC167663
0.8383 Intermediate Similarity NPC66508
0.8383 Intermediate Similarity NPC226656
0.8333 Intermediate Similarity NPC21599
0.8333 Intermediate Similarity NPC193703
0.8323 Intermediate Similarity NPC107109
0.8323 Intermediate Similarity NPC135524
0.8313 Intermediate Similarity NPC478148
0.8313 Intermediate Similarity NPC46882
0.8313 Intermediate Similarity NPC132990
0.8313 Intermediate Similarity NPC232645
0.8313 Intermediate Similarity NPC72958
0.8313 Intermediate Similarity NPC474417
0.8313 Intermediate Similarity NPC149526
0.8303 Intermediate Similarity NPC329933
0.8284 Intermediate Similarity NPC37543
0.8284 Intermediate Similarity NPC199463
0.8282 Intermediate Similarity NPC478019
0.8272 Intermediate Similarity NPC84266
0.8263 Intermediate Similarity NPC470337
0.8263 Intermediate Similarity NPC113608
0.8263 Intermediate Similarity NPC470338
0.8263 Intermediate Similarity NPC470340
0.8263 Intermediate Similarity NPC180944
0.8263 Intermediate Similarity NPC268992
0.8263 Intermediate Similarity NPC51824
0.8263 Intermediate Similarity NPC87708
0.8261 Intermediate Similarity NPC305845
0.8261 Intermediate Similarity NPC204045
0.8256 Intermediate Similarity NPC470081
0.8253 Intermediate Similarity NPC202595
0.8242 Intermediate Similarity NPC172329
0.8242 Intermediate Similarity NPC2569
0.8229 Intermediate Similarity NPC474004
0.8225 Intermediate Similarity NPC5379
0.8225 Intermediate Similarity NPC77807
0.8225 Intermediate Similarity NPC14561
0.8222 Intermediate Similarity NPC99937
0.8218 Intermediate Similarity NPC472058
0.8218 Intermediate Similarity NPC105414
0.8218 Intermediate Similarity NPC470341
0.8218 Intermediate Similarity NPC324522
0.8218 Intermediate Similarity NPC234497
0.8214 Intermediate Similarity NPC214632
0.8214 Intermediate Similarity NPC155686
0.8214 Intermediate Similarity NPC93552
0.821 Intermediate Similarity NPC49108
0.821 Intermediate Similarity NPC182255
0.821 Intermediate Similarity NPC94076
0.8208 Intermediate Similarity NPC472051
0.8208 Intermediate Similarity NPC472057
0.8198 Intermediate Similarity NPC473696
0.8193 Intermediate Similarity NPC158338
0.8193 Intermediate Similarity NPC97028
0.8193 Intermediate Similarity NPC100985
0.8193 Intermediate Similarity NPC65589
0.8193 Intermediate Similarity NPC97029
0.8193 Intermediate Similarity NPC288036
0.8192 Intermediate Similarity NPC477568
0.8187 Intermediate Similarity NPC472052
0.8187 Intermediate Similarity NPC284495
0.8187 Intermediate Similarity NPC472060
0.8187 Intermediate Similarity NPC470342
0.8187 Intermediate Similarity NPC470810
0.8176 Intermediate Similarity NPC178976
0.8176 Intermediate Similarity NPC474637
0.8176 Intermediate Similarity NPC263483
0.8171 Intermediate Similarity NPC470567
0.8171 Intermediate Similarity NPC28632
0.8166 Intermediate Similarity NPC68727
0.8161 Intermediate Similarity NPC477835
0.816 Intermediate Similarity NPC3732
0.815 Intermediate Similarity NPC100849
0.8148 Intermediate Similarity NPC253822
0.8144 Intermediate Similarity NPC280295
0.8144 Intermediate Similarity NPC225854
0.8142 Intermediate Similarity NPC470099
0.814 Intermediate Similarity NPC298401
0.8133 Intermediate Similarity NPC472056
0.8133 Intermediate Similarity NPC27221
0.8133 Intermediate Similarity NPC256672
0.8133 Intermediate Similarity NPC7025
0.8128 Intermediate Similarity NPC154720
0.8121 Intermediate Similarity NPC163846
0.8121 Intermediate Similarity NPC225173
0.8121 Intermediate Similarity NPC300540
0.8114 Intermediate Similarity NPC470566
0.811 Intermediate Similarity NPC475201
0.811 Intermediate Similarity NPC471906
0.811 Intermediate Similarity NPC51887
0.811 Intermediate Similarity NPC475705
0.811 Intermediate Similarity NPC117836
0.811 Intermediate Similarity NPC476178
0.811 Intermediate Similarity NPC244691
0.8107 Intermediate Similarity NPC329844
0.8107 Intermediate Similarity NPC135522
0.8107 Intermediate Similarity NPC210942
0.8107 Intermediate Similarity NPC169990
0.8101 Intermediate Similarity NPC471802
0.8098 Intermediate Similarity NPC321980
0.8098 Intermediate Similarity NPC26051
0.8098 Intermediate Similarity NPC474961
0.8098 Intermediate Similarity NPC55832
0.8098 Intermediate Similarity NPC268204
0.8098 Intermediate Similarity NPC52789
0.8098 Intermediate Similarity NPC470087
0.8095 Intermediate Similarity NPC230848
0.8092 Intermediate Similarity NPC474096
0.8092 Intermediate Similarity NPC472059
0.8086 Intermediate Similarity NPC470211
0.8086 Intermediate Similarity NPC472366
0.8084 Intermediate Similarity NPC10027
0.8084 Intermediate Similarity NPC80370
0.8084 Intermediate Similarity NPC65775
0.8081 Intermediate Similarity NPC472618
0.8081 Intermediate Similarity NPC84571
0.8079 Intermediate Similarity NPC271385
0.8079 Intermediate Similarity NPC5029
0.8079 Intermediate Similarity NPC30432
0.8079 Intermediate Similarity NPC111536
0.8079 Intermediate Similarity NPC76128
0.8072 Intermediate Similarity NPC125801
0.8072 Intermediate Similarity NPC22005
0.8072 Intermediate Similarity NPC123202
0.8072 Intermediate Similarity NPC7943
0.807 Intermediate Similarity NPC201127
0.8061 Intermediate Similarity NPC476055
0.8057 Intermediate Similarity NPC28669
0.8057 Intermediate Similarity NPC474061
0.8054 Intermediate Similarity NPC221185
0.8049 Intermediate Similarity NPC277369
0.8049 Intermediate Similarity NPC215451
0.8047 Intermediate Similarity NPC273483
0.8047 Intermediate Similarity NPC474843
0.8046 Intermediate Similarity NPC472053
0.8043 Intermediate Similarity NPC470100
0.8037 Intermediate Similarity NPC144118
0.8037 Intermediate Similarity NPC204985
0.8037 Intermediate Similarity NPC219917
0.8037 Intermediate Similarity NPC48624
0.8037 Intermediate Similarity NPC213659
0.8037 Intermediate Similarity NPC101366
0.8037 Intermediate Similarity NPC259166
0.8037 Intermediate Similarity NPC172250
0.8037 Intermediate Similarity NPC326109
0.8037 Intermediate Similarity NPC80962
0.8037 Intermediate Similarity NPC215311
0.8036 Intermediate Similarity NPC474660
0.8035 Intermediate Similarity NPC311740
0.8034 Intermediate Similarity NPC472054
0.8034 Intermediate Similarity NPC98776
0.8025 Intermediate Similarity NPC190457
0.8025 Intermediate Similarity NPC242994
0.8025 Intermediate Similarity NPC1268
0.8025 Intermediate Similarity NPC138099
0.8023 Intermediate Similarity NPC472617

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC470560 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8035 Intermediate Similarity NPD6959 Discontinued
0.795 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7886 Intermediate Similarity NPD6232 Discontinued
0.7853 Intermediate Similarity NPD7473 Discontinued
0.7791 Intermediate Similarity NPD7819 Suspended
0.7738 Intermediate Similarity NPD2533 Approved
0.7738 Intermediate Similarity NPD2532 Approved
0.7738 Intermediate Similarity NPD2534 Approved
0.773 Intermediate Similarity NPD1510 Phase 2
0.7719 Intermediate Similarity NPD4380 Phase 2
0.7716 Intermediate Similarity NPD1607 Approved
0.7688 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7644 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7633 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7598 Intermediate Similarity NPD2403 Approved
0.7593 Intermediate Similarity NPD1240 Approved
0.759 Intermediate Similarity NPD1549 Phase 2
0.753 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.753 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7529 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7485 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.7473 Intermediate Similarity NPD5844 Phase 1
0.7471 Intermediate Similarity NPD7411 Suspended
0.7471 Intermediate Similarity NPD7390 Discontinued
0.747 Intermediate Similarity NPD2796 Approved
0.7458 Intermediate Similarity NPD7075 Discontinued
0.7457 Intermediate Similarity NPD3226 Approved
0.7429 Intermediate Similarity NPD6801 Discontinued
0.7429 Intermediate Similarity NPD1934 Approved
0.7386 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7382 Intermediate Similarity NPD4363 Phase 3
0.7382 Intermediate Similarity NPD4360 Phase 2
0.7368 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7308 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.7308 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7308 Intermediate Similarity NPD6166 Phase 2
0.7308 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.7303 Intermediate Similarity NPD3882 Suspended
0.7303 Intermediate Similarity NPD7768 Phase 2
0.7288 Intermediate Similarity NPD2801 Approved
0.7278 Intermediate Similarity NPD5494 Approved
0.7263 Intermediate Similarity NPD3749 Approved
0.7263 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7262 Intermediate Similarity NPD2935 Discontinued
0.7258 Intermediate Similarity NPD6559 Discontinued
0.7254 Intermediate Similarity NPD4362 Clinical (unspecified phase)
0.7254 Intermediate Similarity NPD4361 Phase 2
0.7235 Intermediate Similarity NPD2800 Approved
0.7228 Intermediate Similarity NPD3818 Discontinued
0.7216 Intermediate Similarity NPD6599 Discontinued
0.7207 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.7198 Intermediate Similarity NPD5710 Approved
0.7198 Intermediate Similarity NPD5711 Approved
0.7193 Intermediate Similarity NPD3750 Approved
0.7193 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7186 Intermediate Similarity NPD6651 Approved
0.7168 Intermediate Similarity NPD1511 Approved
0.716 Intermediate Similarity NPD1470 Approved
0.7151 Intermediate Similarity NPD8438 Clinical (unspecified phase)
0.7135 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7118 Intermediate Similarity NPD2346 Discontinued
0.7107 Intermediate Similarity NPD6782 Approved
0.7107 Intermediate Similarity NPD6780 Approved
0.7107 Intermediate Similarity NPD6776 Approved
0.7107 Intermediate Similarity NPD6781 Approved
0.7107 Intermediate Similarity NPD6777 Approved
0.7107 Intermediate Similarity NPD6779 Approved
0.7107 Intermediate Similarity NPD6778 Approved
0.7102 Intermediate Similarity NPD2370 Clinical (unspecified phase)
0.7097 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7086 Intermediate Similarity NPD1512 Approved
0.7079 Intermediate Similarity NPD8151 Discontinued
0.7069 Intermediate Similarity NPD6799 Approved
0.7062 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7059 Intermediate Similarity NPD7074 Phase 3
0.7059 Intermediate Similarity NPD5406 Approved
0.7059 Intermediate Similarity NPD6100 Approved
0.7059 Intermediate Similarity NPD5404 Approved
0.7059 Intermediate Similarity NPD6099 Approved
0.7059 Intermediate Similarity NPD5408 Approved
0.7059 Intermediate Similarity NPD1551 Phase 2
0.7059 Intermediate Similarity NPD5405 Approved
0.7039 Intermediate Similarity NPD37 Approved
0.7021 Intermediate Similarity NPD5953 Discontinued
0.7005 Intermediate Similarity NPD7054 Approved
0.7 Intermediate Similarity NPD7435 Discontinued
0.7 Intermediate Similarity NPD7696 Phase 3
0.7 Intermediate Similarity NPD7697 Approved
0.7 Intermediate Similarity NPD8312 Approved
0.7 Intermediate Similarity NPD8313 Approved
0.7 Intermediate Similarity NPD7698 Approved
0.6995 Remote Similarity NPD8397 Clinical (unspecified phase)
0.6994 Remote Similarity NPD4628 Phase 3
0.6971 Remote Similarity NPD7040 Clinical (unspecified phase)
0.6971 Remote Similarity NPD7041 Phase 2
0.6968 Remote Similarity NPD7472 Approved
0.6965 Remote Similarity NPD7870 Phase 2
0.6965 Remote Similarity NPD7871 Phase 2
0.6964 Remote Similarity NPD943 Approved
0.6961 Remote Similarity NPD3817 Phase 2
0.6961 Remote Similarity NPD5402 Approved
0.6949 Remote Similarity NPD920 Approved
0.6947 Remote Similarity NPD4419 Clinical (unspecified phase)
0.6931 Remote Similarity NPD6797 Phase 2
0.6931 Remote Similarity NPD7993 Clinical (unspecified phase)
0.6923 Remote Similarity NPD4966 Approved
0.6923 Remote Similarity NPD4965 Approved
0.6923 Remote Similarity NPD4967 Phase 2
0.6919 Remote Similarity NPD2344 Approved
0.6915 Remote Similarity NPD7286 Phase 2
0.6914 Remote Similarity NPD1201 Approved
0.6906 Remote Similarity NPD1465 Phase 2
0.6901 Remote Similarity NPD3748 Approved
0.6901 Remote Similarity NPD2799 Discontinued
0.6897 Remote Similarity NPD6398 Clinical (unspecified phase)
0.6897 Remote Similarity NPD7003 Approved
0.6895 Remote Similarity NPD7251 Discontinued
0.6891 Remote Similarity NPD8150 Discontinued
0.6872 Remote Similarity NPD7458 Discontinued
0.6863 Remote Similarity NPD7701 Phase 2
0.6862 Remote Similarity NPD3751 Discontinued
0.6859 Remote Similarity NPD4338 Clinical (unspecified phase)
0.6859 Remote Similarity NPD7808 Phase 3
0.6857 Remote Similarity NPD3887 Approved
0.6854 Remote Similarity NPD5403 Approved
0.6853 Remote Similarity NPD6534 Approved
0.6853 Remote Similarity NPD6535 Approved
0.6848 Remote Similarity NPD6234 Discontinued
0.6839 Remote Similarity NPD1243 Approved
0.6836 Remote Similarity NPD7004 Clinical (unspecified phase)
0.6836 Remote Similarity NPD7422 Clinical (unspecified phase)
0.6796 Remote Similarity NPD7875 Clinical (unspecified phase)
0.6796 Remote Similarity NPD7874 Approved
0.6791 Remote Similarity NPD3926 Phase 2
0.6786 Remote Similarity NPD4625 Phase 3
0.6782 Remote Similarity NPD6823 Phase 2
0.6776 Remote Similarity NPD2379 Clinical (unspecified phase)
0.6766 Remote Similarity NPD7501 Clinical (unspecified phase)
0.6763 Remote Similarity NPD7801 Approved
0.6761 Remote Similarity NPD2354 Approved
0.6761 Remote Similarity NPD2309 Approved
0.676 Remote Similarity NPD6980 Clinical (unspecified phase)
0.675 Remote Similarity NPD7700 Phase 2
0.675 Remote Similarity NPD7699 Phase 2
0.6746 Remote Similarity NPD4907 Clinical (unspecified phase)
0.6746 Remote Similarity NPD6859 Clinical (unspecified phase)
0.6742 Remote Similarity NPD642 Clinical (unspecified phase)
0.6742 Remote Similarity NPD5401 Approved
0.6738 Remote Similarity NPD7229 Phase 3
0.6723 Remote Similarity NPD643 Clinical (unspecified phase)
0.6707 Remote Similarity NPD2798 Approved
0.6705 Remote Similarity NPD651 Clinical (unspecified phase)
0.6704 Remote Similarity NPD6273 Approved
0.6684 Remote Similarity NPD1247 Approved
0.6684 Remote Similarity NPD7228 Approved
0.6684 Remote Similarity NPD7177 Discontinued
0.6667 Remote Similarity NPD3972 Approved
0.6667 Remote Similarity NPD919 Approved
0.6649 Remote Similarity NPD3787 Discontinued
0.6648 Remote Similarity NPD1578 Phase 2
0.6647 Remote Similarity NPD4538 Approved
0.6647 Remote Similarity NPD4537 Clinical (unspecified phase)
0.6647 Remote Similarity NPD2313 Discontinued
0.6647 Remote Similarity NPD3764 Approved
0.6647 Remote Similarity NPD4536 Approved
0.6634 Remote Similarity NPD8320 Phase 1
0.6634 Remote Similarity NPD8319 Approved
0.6633 Remote Similarity NPD8434 Phase 2
0.6633 Remote Similarity NPD6212 Phase 3
0.6633 Remote Similarity NPD6214 Clinical (unspecified phase)
0.6633 Remote Similarity NPD6213 Phase 3
0.663 Remote Similarity NPD5760 Phase 2
0.663 Remote Similarity NPD5761 Phase 2
0.6629 Remote Similarity NPD2353 Approved
0.6629 Remote Similarity NPD1471 Phase 3
0.6629 Remote Similarity NPD2355 Clinical (unspecified phase)
0.6628 Remote Similarity NPD230 Phase 1
0.6627 Remote Similarity NPD4908 Phase 1
0.6626 Remote Similarity NPD1651 Approved
0.6617 Remote Similarity NPD8090 Clinical (unspecified phase)
0.6611 Remote Similarity NPD1940 Clinical (unspecified phase)
0.6607 Remote Similarity NPD6917 Clinical (unspecified phase)
0.6603 Remote Similarity NPD7783 Phase 2
0.6603 Remote Similarity NPD7782 Clinical (unspecified phase)
0.6597 Remote Similarity NPD7893 Clinical (unspecified phase)
0.6596 Remote Similarity NPD7199 Phase 2
0.6587 Remote Similarity NPD1283 Approved
0.6583 Remote Similarity NPD3819 Phase 2
0.6582 Remote Similarity NPD8055 Clinical (unspecified phase)
0.6568 Remote Similarity NPD454 Approved
0.6566 Remote Similarity NPD4878 Approved
0.6554 Remote Similarity NPD2654 Approved
0.655 Remote Similarity NPD6410 Clinical (unspecified phase)
0.6543 Remote Similarity NPD3365 Discontinued
0.6522 Remote Similarity NPD958 Approved
0.6514 Remote Similarity NPD5588 Approved
0.6514 Remote Similarity NPD5960 Phase 3
0.6514 Remote Similarity NPD7033 Discontinued
0.6506 Remote Similarity NPD1547 Clinical (unspecified phase)
0.6497 Remote Similarity NPD4534 Discontinued

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data